Z
Zhuoyin Xue
Researcher at Xi'an Jiaotong University
Publications - 8
Citations - 47
Zhuoyin Xue is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 1, co-authored 4 publications receiving 12 citations.
Papers
More filters
Journal ArticleDOI
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.
TL;DR: DEX inhibits the entrance of SARS-CoV-2 spike pseudotyped virus into cell by binding to ACE2, and cell membrane chromatography results uncovered that DEX had a chromatographic retention.
Journal ArticleDOI
Licochalcone A inhibits MAS-related GPR family member X2-induced pseudo-allergic reaction by suppressing nuclear migration of nuclear factor-κB.
Zhuoyin Xue,Yongjing Zhang,Yingnan Zeng,Shiling Hu,Haoyun Bai,Jue Wang,Huiling Jing,Nan Wang +7 more
TL;DR: In this article, the anti-pseudo-allergic effect of Lico A and its underlying mechanism was investigated using passive cutaneous anaphylaxis (PCA) and active systemic allergy, along with degranulation, Ca2+ influx in vitro.
Journal ArticleDOI
Chrysin Inhibits Pseudo-allergic Reaction by Suppressing Mitochondrial STAT3 Activation via MAS-Related GPR Family Member X2
TL;DR: In this article, the anti-pseudo allergy effect of chrysin and its underlying mechanisms were studied in vitro and in vivo, and it was shown that Chrysin inhibited passive cutaneous anaphylaxis and systemic pseudo-allergy in vivo.
Journal ArticleDOI
Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein.
TL;DR: In this paper, the authors investigated the inhibition effect of valaciclovir hydrochloride (VACV), zidovudine (ZDV), saquinavir (SQV), and efavirenz (EFV) on 2019-nCoV infection.
Posted ContentDOI
Harringtonine has the effects of double blocking SARS-CoV-2 membrane fusion
Shiling Hu,Nan Wang,Shaohong Chen,Qiang Ding,Cheng Wang,Weina Ma,Xinghai Zhang,Yan Wu,Yanni Lv,Zhuoyin Xue,Haoyun Bai,Shuai Ge,Huaizhen He,Wen Lu,Tao Zhang,Yuanyuan Ding,Ruiqiang Li,Shengli Han,Yingzhuan Zhan,Guanqun Zhan,Zebin Guo,Yongjing Zhang,Jiayu Lu,Jiapan Gao,Qianqian Jia,Yuejin Wang,Hongliang Wang,Shemin Lu,Huajun Zhang,Langchong He +29 more
TL;DR: The findings show that HT is a potential small-molecule antagonist with a new mechanism of action against SARS-CoV-2 infection, and thus HT greatly reduces the damage of the S protein’s autotoxicity to the organ system, has promising advantages in the clinical treatment of COVID-19.